MNRO Q1 2026 Earnings EPS Surpasses Estimates as Cost Management Drives Profitability CryoPort Inc CYRX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges ALLT Q1 2026 Earnings EPS Surprises to the Upside Amid Strong Operational Performance Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress